PCC 2020

WHAT TO EXPECT

Enforcement and Oversight

Gary Cantrell, Deputy Inspector General for Investigations, Office of Inspector General (OIG), Department of Health and Human Services (HHS)

Craig Carpenito, U.S. Attorney, U.S. Attorney’s Office for the District of New Jersey

Rachael Honig, First Assistant U.S. Attorney, U.S. Attorney’s Office for the District of New Jersey

Amanda Masselam Strachan, Chief, Health Care Fraud Unit, U.S. Attorney’s Office for the District of Massachusetts

Gregg Shapiro, Assistant U.S. Attorney, U.S Attorney’s Office for the District of Massachusetts

Jason Swergold, Co-Chief, Narcotics Unit, U.S. Attorney’s Office for the Southern District of New York

Robert Dodge, Assistant Director, FCPA Unit, U.S. Securities and Exchange Commission (SEC)

Gustav Eyler, Director, Consumer Protection Branch, U.S. Department of Justice (DOJ)

Leadership and Innovation

John Crowley, Chairman of the Board, Chief Executive Officer, Amicus Therapeutics

Joshua Marks, Vice President, Chief Ethics and Compliance Officer, Boehringer Ingelheim

Tina Beamon, Vice President, Chief Compliance Officer, Karyopharm Therapeutics, Inc

Bryant Aaron, Vice President, Chief Compliance, Officer, U.S. Country Head, Ethics and Compliance, Novartis Pharmaceuticals Corporation

Jill Fallows Macaluso, Corporate Vice President, North America, Chief Ethics, Compliance and Privacy Officer, Novo Nordisk

Indrani Lall Franchini, Executive Vice President and Chief Compliance Officer, Alexion Pharmaceuticals, Inc.

Jim Flaherty, Vice President, Associate General Counsel, Rhythm Pharmaceuticals

Kelly Payne, Vice President, Global Ethics and Compliance Officer, Eli Lilly and Company

Jeffrey Levitt, Vice President, Head of Legal Affairs and Compliance, Stemline

Best Practices and Frameworks

• Spotlight on Digital Health Initiatives Across the Value Chain Transforming the Life Sciences Sector
• Compliant Patient Interactions from Clinical to Commercial
• Commercial and Government Pricing Transparency and Reporting
• Legal Watch-Outs for Partnering and Deal-Making
• Strategies for Field Team Compliance
• Third-Party Risk Assessment and Oversight
• Hub and Specialty Pharmacy Contract Oversight and Risk Assessment
• Patient Data and How It Impacts HIPAA, CCPA, GDPR and Overall Organizational Integrity
• International Trends, Regulations and Best Practices Around the World for Global Compliance
• Medical Affairs Compliance
• Product Communication — From Pre-Approval to Post-Approval
• Clinical Trial Legal and Contracting Considerations and Risk Management Strategies
• Speaker Programs — Current and Future Trends
• Spotlight on Auditing, Monitoring and Data Analytics